Pro Medicus マネジメント

マネジメント基準チェック /44

Pro Medicusの CEO はSam Hupertで、 Jan1983年に任命され、の在任期間は 41.83年です。の年間総報酬はA$ 965.22Kで、 95.5%給与と4.5%のボーナス（会社の株式とオプションを含む）で構成されています。は、会社の株式の24.06%を直接所有しており、その価値は€ 3.48B 。経営陣と取締役会の平均在任期間はそれぞれ11年と8.5年です。

主要情報

Sam Hupert

最高経営責任者

AU$965.2k

報酬総額

CEO給与比率	95.5%
CEO在任期間	41.8yrs
CEOの所有権	24.1%
経営陣の平均在職期間	11yrs
取締役会の平均在任期間	8.5yrs

経営陣の近況

Recent updates

CEO報酬分析

Pro Medicus の収益と比較して、Sam Hupert の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2024	AU$965k	AU$921k	AU$83m
Mar 31 2024	n/a	n/a	AU$76m
Dec 31 2023	n/a	n/a	AU$70m
Sep 30 2023	n/a	n/a	AU$65m
Jun 30 2023	AU$1m	AU$723k	AU$61m
Mar 31 2023	n/a	n/a	AU$56m
Dec 31 2022	n/a	n/a	AU$51m
Sep 30 2022	n/a	n/a	AU$48m
Jun 30 2022	AU$510k	AU$475k	AU$44m
Mar 31 2022	n/a	n/a	AU$41m
Dec 31 2021	n/a	n/a	AU$38m
Sep 30 2021	n/a	n/a	AU$34m
Jun 30 2021	AU$508k	AU$475k	AU$31m
Mar 31 2021	n/a	n/a	AU$28m
Dec 31 2020	n/a	n/a	AU$25m
Sep 30 2020	n/a	n/a	AU$24m
Jun 30 2020	AU$508k	AU$475k	AU$23m
Mar 31 2020	n/a	n/a	AU$23m
Dec 31 2019	n/a	n/a	AU$22m
Sep 30 2019	n/a	n/a	AU$21m
Jun 30 2019	AU$508k	AU$475k	AU$19m
Mar 31 2019	n/a	n/a	AU$17m
Dec 31 2018	n/a	n/a	AU$16m
Sep 30 2018	n/a	n/a	AU$13m
Jun 30 2018	AU$518k	AU$475k	AU$10m

報酬と市場: Samの総報酬 ($USD 627.26K ) は、 German市場 ($USD 4.77M ) の同様の規模の企業の平均を下回っています。

報酬と収益: Samの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Sam Hupert

41.8yrs

在職期間

AU$965,221

報酬

Dr. Sam Aaron Hupert, M.B.B.S., MD has been the Chief Executive Officer and Managing Director at Pro Medicus Limited (alternate name: PRO Medicus Ltd.) since October 2010. Dr. Hupert serves as Member of Ad...

リーダーシップ・チーム

名称	ポジション	在職期間	報酬	所有権
Sam Hupert	Co-Founder	41.8yrs	AU$965.22k	24.06% € 3.5b
Anthony Hall	Co-Founder	41.8yrs	AU$373.26k	24.03% € 3.5b
Clayton Hatch	Chief Financial Officer	12.3yrs	AU$500.77k	0.034% € 4.9m
Malte Westerhoff	GM of Europe & Global CTO	no data	AU$1.59m	0.099% € 14.3m
Brad Levin	GM of North America & Global Head of Marketing	no data	AU$401.25k	データなし
Sharni Redenbach	People & Culture Director	2.3yrs	データなし	データなし
Sean Lambright	Global Head of Sales - Visage Imaging Inc	9.3yrs	AU$1.21m	0.17% € 24.6m
Teresa Gschwind	Global Head of Customer Service of Visage Imaging Inc.	no data	データなし	データなし
Danny English	Financial Controller & Company Secretary	9.7yrs	データなし	データなし

11.0yrs

平均在職期間

経験豊富な経営陣: PMCの経営陣は経験豊富で経験豊富です（平均在職期間は11年）。

取締役

名称	ポジション	在職期間	報酬	所有権
Sam Hupert	Co-Founder	41.8yrs	AU$965.22k	24.06% € 3.5b
Anthony Hall	Co-Founder	41.8yrs	AU$373.26k	24.03% € 3.5b
Alice Joans Williams	Independent Non-Executive Director	3.2yrs	AU$125.00k	0.0020% € 284.9k
Leigh Farrell	Independent Non-Executive Director	7.2yrs	AU$125.00k	0.0041% € 587.1k
Peter Kempen	Chairman	16.7yrs	AU$250.00k	0.30% € 43.5m
Deena Shiff	Independent Non-Executive Director	4.3yrs	AU$125.00k	0.0018% € 266.1k
Anthony Glenning	Independent Non-Executive Director	8.5yrs	AU$125.00k	0.0091% € 1.3m

8.5yrs

平均在職期間

経験豊富なボード: PMCの取締役会は経験豊富であると考えられます ( 8.5年の平均在任期間)。

Pro Medicus マネジメント

マネジメント 基準チェック /44

主要情報

経営陣の近況

Pro Medicus Limited, Annual General Meeting, Nov 25, 2024

Co-Founder recently sold €53m worth of stock

Pro Medicus Limited, Annual General Meeting, Nov 20, 2023

Insufficient new directors

Chairman recently sold €1.9m worth of stock

Pro Medicus Limited, Annual General Meeting, Nov 21, 2022

Recent updates

Pro Medicus Limited, Annual General Meeting, Nov 25, 2024

Final dividend of AU$0.22 announced

New major risk - Earnings quality

Full year 2024 earnings released: EPS: AU$0.79 (vs AU$0.58 in FY 2023)

Pro Medicus Limited to Report Fiscal Year 2024 Results on Aug 14, 2024

Upcoming dividend of AU$0.18 per share

First half dividend of AU$0.18 announced

First half 2024 earnings released: EPS: AU$0.35 (vs AU$0.26 in 1H 2023)

Pro Medicus Limited to Report First Half, 2024 Results on Feb 15, 2024

Co-Founder recently sold €53m worth of stock

New minor risk - Insider selling

Pro Medicus Limited, Annual General Meeting, Nov 20, 2023

Insufficient new directors

Upcoming dividend of AU$0.17 per share at 0.5% yield

New major risk - Earnings quality

Full year 2023 earnings released: EPS: AU$0.58 (vs AU$0.43 in FY 2022)

Pro Medicus Limited to Report Fiscal Year 2023 Final Results on Aug 15, 2023

Chairman recently sold €1.9m worth of stock

Upcoming dividend of AU$0.13 per share at 0.4% yield

First half 2023 earnings released: EPS: AU$0.26 (vs AU$0.20 in 1H 2022)

Pro Medicus Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 24, 2023

Pro Medicus Limited to Report First Half, 2023 Results on Feb 15, 2023

Pro Medicus Limited, Annual General Meeting, Nov 21, 2022

Upcoming dividend of AU$0.12 per share

Full year 2022 earnings released: EPS: AU$0.43 (vs AU$0.30 in FY 2021)

Pro Medicus Limited Announces Fully Franked Ordinary Dividend for the Period of Twelve Months Ended June 30, 2022, Payable on September 30, 2022

Pro Medicus Limited to Report Q4, 2022 Results on Aug 18, 2022

Upcoming dividend of AU$0.10 per share

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

Pro Medicus Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 25, 2022

Pro Medicus Limited to Report First Half, 2022 Results on Feb 16, 2022

Upcoming dividend of AU$0.08 per share

Full year 2021 earnings released: EPS AU$0.30 (vs AU$0.22 in FY 2020)

New 90-day high: €30.54

Upcoming Dividend of AU$0.07 Per Share

Co-Founder recently sold €30m worth of stock

Revenue misses expectations

First half 2021 earnings released: EPS AU$0.13 (vs AU$0.12 in 1H 2020)

New 90-day high: €27.85

Pro Medicus Limited to Report First Half, 2021 Results on Feb 17, 2021

Pro Medicus Limited receives FDA approval for Breast Density Algorithm

New 90-day high: €23.11

New 90-day high: €20.91

New 90-day high: €20.58

New 90-day high: €17.07

Earnings released

Pro Medicus Limited to Report Fiscal Year 2020 Results on Aug 20, 2020

New 90-day low - €14.22

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

リーダーシップ・チーム

平均在職期間

取締役

平均在職期間

マネジメント基準チェック /44